ArticleBMC geriatrics2026
The role of dynamic Lowenstein occupational therapy and cognitive assessment scale for the elderly with Parkinson's disease.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06131619 (The Role of Dynamic Lowenstein Occupational Therapy Cognitive Assessment-Geriatric Version), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Role of Dynamic Lowenstein Occupational Therapy Cognitive Assessment-Geriatric Version (DLOTCA-G) in the Cognitive Function Evaluation of Parkinson's Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive impairments in Parkinson's disease (PD) commonly affect executive function, attention, and visuospatial abilities. These deficits may precede motor symptoms and are often undetected by screening tools such as the Standardized Mini-Mental State Examination (SMMSE). The utility of the Dynamic Lowenstein Occupational Therapy Cognitive Assessment-Geriatric Version (DLOTCA-G) has not been evaluated in older adults with PD. This study aims to investigate the effectiveness of DLOTCA-G in detecting cognitive deficits in PD patients with and without cognitive impairment.
methodsIn this prospective controlled study, 90 participants aged 65 and above were recruited: 30 PD patients with cognitive impairment (PD-CI), 30 PD patients without cognitive impairment (PD-NCI), and 30 healthy controls. All participants underwent cognitive assessment using SMMSE and DLOTCA-G. The total SMMSE score and eight subscales of the DLOTCA-G were analyzed.
resultsExcept for the spatial perception score, there was a statistically significant difference between the groups in all DLOTCA-G subscales. The PD-CI group had significantly lower awareness and visuomotor construction scores than the PD-NCI and healthy groups (p < 0.01). The PD-NCI group showed significantly lower awareness and visuomotor construction scores than the healthy group (p < 0.01). Total SMMSE scores showed a moderate positive correlation with orientation, praxis, visuomotor construction, and thinking operations (p < 0.01). In the Parkinson's group (n = 60), SMMSE Orientation correlated strongly with DLOTCA-G Orientation, Visuomotor Construction, and Awareness (p < 0.001). SMMSE Attention/Calculation and Language showed moderate associations with praxis and visuomotor domains (p ≤ 0.001; Table 4).
conclusionThe results indicate that DLOTCA-G subscales associated with executive function are impaired in individuals with PD, even in the absence of cognitive impairment. These findings suggest that DLOTCA-G may offer a more differentiated cognitive profile than SMMSE across multiple domains, although its comparative sensitivity and diagnostic accuracy require further validation in studies using comprehensive neuropsychological references.
trial registrationThe study was retrospectively registered (registration number NCT06131619), prospective registration prior to participant enrollment was not completed due to logistical reasons. Protocol adherence was maintained throughout the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.